Sandra M Gurrola
CIK 1618457 · Sr. VP of Finance · last filed 2025-07-07
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
Loading insider history…
Disclosed Exposure
$153.8K
Companies
3
Total Filings
46
Lifetime Open-Market Net
$0
Holdings By Company
Latest on-record share count from this person's most recent non-derivative Form 4 transaction in each company. Disclosed exposure = shares × current underlying price.
| Symbol | Role | Shares | Price | Disclosed Exposure | Lifetime OM Net | Filings | Latest Filed |
|---|---|---|---|---|---|---|---|
| ERNA | Sr. VP of Finance | 110 | $6.15 | $676 | $0 | 5 | 2025-07-07 |
| BTX | Vice President of Finance | 16,953 | $9.03 | $153.1K | $0 | 4 | 2022-06-23 |
| Ernexa Therapeutics Inc. (NTN) Delisted | Former SVP of Finance | 21,617 | $2.70 | $58.4K | $0 | 35 | 2021-03-26 |
Recent Filings · Page 3 of 5
46 filingsForm 4 transactions across all companies, newest first.
| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2020-05-20 | Ernexa Therapeutics Inc. (NTN) Delisted | Tax (F) | −115 | -$178 | EDGAR |
| 2020-04-22 | Ernexa Therapeutics Inc. (NTN) Delisted | Tax (F) | −1,392 | -$1.7K | EDGAR |
| 2020-03-25 | Ernexa Therapeutics Inc. (NTN) Delisted | Tax (F) | −114 | -$169 | EDGAR |
| 2020-02-26 | Ernexa Therapeutics Inc. (NTN) Delisted | Tax (F) | −115 | -$236 | EDGAR |
| 2020-01-31 | Ernexa Therapeutics Inc. (NTN) Delisted | Mixed | +24,886 | -$277 | EDGAR |
| 2019-12-20 | Ernexa Therapeutics Inc. (NTN) Delisted | Tax (F) | −94 | -$257 | EDGAR |
| 2019-11-20 | Ernexa Therapeutics Inc. (NTN) Delisted | Tax (F) | −95 | -$249 | EDGAR |
| 2019-10-23 | Ernexa Therapeutics Inc. (NTN) Delisted | Tax (F) | −94 | -$271 | EDGAR |
| 2019-09-24 | Ernexa Therapeutics Inc. (NTN) Delisted | Tax (F) | −454 | -$1.0K | EDGAR |
| 2019-08-27 | Ernexa Therapeutics Inc. (NTN) Delisted | Tax (F) | −35 | -$97 | EDGAR |
Codes: P = open-market purchase · S = open-market sale · A = grant/award · M = option exercise · F = tax withholding at vest · G = bona-fide gift · D = disposition to issuer · J = other (see filing footnote). Only P / S codes carry directional signal.